These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1690477)

  • 41. [Therapy of benign prostatic hyperplasia with alpha receptor blockers].
    Stockamp K
    Urologe A; 1995 Jan; 34(1):3-8. PubMed ID: 7533449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin A injection to the bladder neck and urethra for medically refractory lower urinary tract symptoms in men without prostatic obstruction.
    Chen JL; Chen CY; Kuo HC
    J Formos Med Assoc; 2009 Dec; 108(12):950-6. PubMed ID: 20040460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is it possible to predict post-residual voided urine by bladder scan before uroflowmetry--a useful and timesaving test to reduce the number of non--evaluable uroflow measurements?
    Dicuio M; Vesely S; Knutson T; Damber JE; Cuzzocrea DE; Dahlstrand C
    Arch Ital Urol Androl; 2010 Jun; 82(2):100-4. PubMed ID: 20812533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical efficacy and safety of long-term administration of YM617 for urinary obstruction of the lower urinary tract].
    Yoshida O; Takeuchi H; Hida S; Tomoyoshi T; Arai Y; Okada K; Akino H; Isomatsu ; Okabe T; Fukuyama T
    Hinyokika Kiyo; 1991 Apr; 37(4):421-9. PubMed ID: 1716407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The mechanism of action of the alpha-adrenoblocker prazosin on bladder function in patients with benign prostatic hyperplasia].
    Loran OB; Vishnevskiĭ AE
    Urol Nefrol (Mosk); 1997; (4):19-22. PubMed ID: 9381614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of benign prostatic hyperplasia with phytosterols.
    Carbin BE; Larsson B; Lindahl O
    Br J Urol; 1990 Dec; 66(6):639-41. PubMed ID: 1702340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of detrusor activity during micturition in patients with benign prostatic enlargement with a clinical nomogram.
    Rosier PF; de Wildt MJ; Debruyne FM; Wijkstra H; de la Rosette JJ
    J Urol; 1996 Aug; 156(2 Pt 1):473-8; discussion 478-9. PubMed ID: 8683707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical overview of prazosin in the treatment of prostatic obstruction.
    Milroy E
    Urol Int; 1990; 45 Suppl 1():1-3. PubMed ID: 1690474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
    Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
    Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical effect of new alpha-adrenergic blocker on micturition disturbance of neurogenic bladder and lower urinary tract obstruction].
    Takimoto Y; Kitamura K; Fuse T; Kawazoe K; Hirano D; Amagai T; Kiyotaki S
    Hinyokika Kiyo; 1983 Feb; 29(2):255-63. PubMed ID: 6145342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.
    Kessler TM; Studer UE; Burkhard FC
    J Urol; 2006 Oct; 176(4 Pt 1):1487-92. PubMed ID: 16952666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indoramin--an effective new drug in the management of bladder outflow obstruction.
    Iacovou JW; Dunn M
    Br J Urol; 1987 Dec; 60(6):526-8. PubMed ID: 2447995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic effect of Robaveron tablet (KN-7) on urinary disturbance by benign prostatic hypertrophy].
    Sonoda T; Endo H; Maru A; Sasaki K; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1985 Mar; 31(3):553-62. PubMed ID: 2411118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rational approach to the patient with urination disorders caused by cervico-urethral obstruction].
    Petta S; Aloisi P; Martis G; Iaboni L; Ruo A; Arrighi M
    Minerva Urol Nefrol; 2000 Dec; 52(4):207-10. PubMed ID: 11315331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Incidence of the form and caliber of urethral resistance. Evaluation for a normal masculine urethra and in cases of obstruction due to prostatic hypertrophy].
    Glémain P; Cordonnier JP; Bochereau G; Baron M; Le Normand L; Buzelin JM
    Prog Urol; 1993 Dec; 3(6):995-1015; discussion 1006-8. PubMed ID: 7508314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction.
    Yazaki J; Aikawa K; Shishido K; Yanagida T; Nomiya M; Ishibashi K; Haga N; Yamaguchi O
    Neurourol Urodyn; 2011 Mar; 30(3):461-7. PubMed ID: 20886573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.